NSCLCnon-small cell lung cancerstage II-III NSCLCpembrolizumabatezolizumabchemoradiotherapydurvalumabosimertinib
…rapy for early and locally advanced non-small cell lung cancer (NSCLC). However, these novel drugs are costly, posing a funding chall…
Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…rapy for early and locally advanced non-small cell lung cancer (NSCLC). However, these novel drugs are costly, posing a funding chall…
…s (CE) of adjuvant, neoadjuvant and perioperative therapies for stage II–III non-small-cell lung cancer: results based on 1000 Monte-Carlo simulations (male population…